New Results
Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells
Marianne R. Spalinger, Rong Hai, Jiang Li, Alina N. Santos, View ORCID ProfileTara M. Nordgren, View ORCID ProfileMichel L. Tremblay, View ORCID ProfileLars Eckmann, Elaine Hanson, View ORCID ProfileMichael Scharl, View ORCID ProfileXiwei Wu, View ORCID ProfileBrigid S. Boland, View ORCID ProfileDeclan F. McCole
doi: https://doi.org/10.1101/2020.12.09.416586
Marianne R. Spalinger
1Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA
2Department of Gastroenterology and Hepatology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland
Rong Hai
3Department of Microbiology & Plant Pathology, University of California Riverside, Riverside, California, USA
Jiang Li
1Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA
Alina N. Santos
1Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA
Tara M. Nordgren
1Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA
Michel L. Tremblay
4Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada
Lars Eckmann
5Division of Gastroenterology, University of California San Diego, La Jolla, California, USA
Elaine Hanson
5Division of Gastroenterology, University of California San Diego, La Jolla, California, USA
Michael Scharl
2Department of Gastroenterology and Hepatology, University Hospital Zurich, and University of Zurich, Zurich, Switzerland
Xiwei Wu
6Integrative Genomics Core, Beckman Research Institute of City of Hope, Monrovia, California, USA
Brigid S. Boland
5Division of Gastroenterology, University of California San Diego, La Jolla, California, USA
Declan F. McCole
1Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA
Article usage
Posted December 09, 2020.
Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells
Marianne R. Spalinger, Rong Hai, Jiang Li, Alina N. Santos, Tara M. Nordgren, Michel L. Tremblay, Lars Eckmann, Elaine Hanson, Michael Scharl, Xiwei Wu, Brigid S. Boland, Declan F. McCole
bioRxiv 2020.12.09.416586; doi: https://doi.org/10.1101/2020.12.09.416586
Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells
Marianne R. Spalinger, Rong Hai, Jiang Li, Alina N. Santos, Tara M. Nordgren, Michel L. Tremblay, Lars Eckmann, Elaine Hanson, Michael Scharl, Xiwei Wu, Brigid S. Boland, Declan F. McCole
bioRxiv 2020.12.09.416586; doi: https://doi.org/10.1101/2020.12.09.416586
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14179)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16802)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)